Menu

Exact Sciences Corporation EXAS

Full chart Compare
Set alert

Price alert · EXAS

All alert types
104.91 USD 0.00 (+0.00%)

Mar 23, 2026, 9:30 AM EDT

104.91 Day range 104.91

52-week range unavailable

YTD
+3.30%
1 year
+129.96%

Revenue & Expenses

Revenue by
Other Operating Income → Expenses: $99.94MScreening → Revenue: $2.53BExpenses → Selling, General & Admin: $1.94BExpenses → Research & Development: $523.00MExpenses → Interest Expense: $32.87MExpenses → Other Expenses: $71.94MExpenses → Income Tax: $4.06MGross Profit → Expenses: $2.26BRevenue → Gross Profit: $2.26BRevenue → Cost of Revenue: $984.15MPrecision Oncology → Revenue: $717.12MNet Loss → Expenses: $207.95MOther Operating Income$99.94MGross Profit$2.26BNet Loss$207.95MCost of Revenue$984.15MExpenses$2.57BSelling, General & Admin$1.94BResearch & Development$523.00MInterest Expense$32.87MOther Expenses$71.94MIncome Tax$4.06MRevenue$3.25BScreening$2.53BPrecision Oncology$717.12M

Latest period ending Dec 31, 2025 · select a line to chart its full history

EXAS annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
3.25B2.76B2.50B2.08B1.77B
2.26B1.92B1.76B1.42B1.31B
-206.30M-1.05B-215.01M-593.51M-855.68M
-207.95M-1.03B-204.15M-623.51M-595.63M
-1.10-5.59-1.13-3.54-3.48
EXAS annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
956.00M600.89M605.38M242.49M315.47M
5.86B5.93B6.47B6.23B6.68B
3.46B3.53B3.33B3.18B3.30B
2.52B2.75B2.55B2.45B2.38B
2.40B2.40B3.15B3.04B3.39B
EXAS annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
491.44M210.54M156.12M-223.56M-102.24M
195.12M-442.15M49.68M74.07M-1.08B
-338.09M231.87M159.77M76.48M8.47M
-134.66M-135.99M-124.19M-189.46M-135.77M
349.36M-3.04M366.88M-72.98M-1.18B